Upregulation of Talin-1 expression is documented in gastric cancer, mucosal SCC, and prostate cancers; conversely, its downregulation is shown in colorectal cancer and hepatocellular carcinoma [34–39]. This evidence concerns the gene TLN1 and prostate cancer.